Red yisti shinkafa (RYR) shi ne kariyar abincin da aka sayar da shi azaman samfurin kwaya don rage yawan cholesterol .
An yi amfani da RYR a kasar Sin tsawon ƙarni duka a cikin dafa abinci da kuma magance matsalolin ƙwayoyin cuta da ƙwayoyin cuta. Duk da haka, tun lokacin da aka yi amfani dashi a Amurka don lokaci mafi tsawo, ya haifar da rikici mai mahimmanci.
Menene Rice Yisti Gishiri?
RYR shine kayan shinkafa wanda aka yi da shinkafa da shinkafa tare da makircin Monascus purpureus .
Ya ƙunshi abubuwa da yawa waɗanda zasu iya rage matakan cholesterol, ciki har da beta-sterols , acid mai fatalwa da kuma statin . Sunan sunadarai na statin wanda ya nuna a cikin RYR shine monocolin K, amma an san mafi kyau a Amurka a matsayin lovastatin (aka sayar da Mevacor).
Shin RYR Lower Cholesterol?
Nazarin sun nuna cewa RYR, kamar yadda aka samar a kasar Sin da kuma yadda aka sayar da ita a matsayin abincin da ake ci a cikin Amurka, hakika ya rage matakin LDL cholesterol .
Alal misali, a cikin nazarin marasa lafiya 83 da tsadar cholesterol mai daraja, wadanda aka bazu zuwa RYR suna da raguwa mai yawa a total cholesterol (204 vs 338 MG / dL) da kuma LDL cholesterol matakan (128 vs. 277 MG / dL) bayan makonni takwas, idan aka kwatanta da wadanda ke daukar wuri.
Wannan rikici
Tambaya, ba shakka, shine RYR ya ƙunshi statin. Statins, bisa ga doka, su ne kwayoyi kuma saboda haka suna ƙarƙashin tsarin.
Tambayar ta fara a 1999, jim kadan bayan gwaji na asibiti ya nuna cewa RYR zai iya rage yawan ƙwayar cholesterol. A wannan lokacin FDA ta yi mulkin cewa RYR wanda ke dauke da monocolin K wani maganin miyagun ƙwayoyi, don haka ya umarce shi ya cire shi daga ɗakunan. Bayanan da aka yanke, kuma (bayan da aka yanke hukuncin kisa) Kotun Kotu na Tarayyar Amurka ta 10 ta yarda da FDA.
Don haka, a Amurka, RYR har yanzu ana iya sayar da doka, amma idan an dauki matakai a tsarin sarrafa shi don cire monocolin K.
RYR har yanzu yana samuwa a matsayin kari na abincin, kuma yawancin masana'antun sun samar da su. A matsayin kari na abinci, tsarinsa da abun ciki ba har yanzu an tsara shi ba. Yana da matukar wuya idan ba zai iya yiwuwa a gano abin da samfurin RYR na musamman yake a kan ɗakunan ba.
Bincike
Duk da wannan rikice-rikice, gwajin gwaji biyu sun bayyana cewa har ma a lokacin FDA, akalla wasu RYR da ke cikin Amurka suna da tasiri wajen rage ƙwayar cholesterol.
A shekara ta 2009, wani binciken daga Pennsylvania ya nuna cewa a cikin marasa lafiya 60 da suka dakatar da shan magungunan kwayoyi saboda ciwo mai tsoka , sun dauki RYR da kuma farawa canjin rayuwa tsawon makonni 24 da muhimmanci ya rage yawan nauyin LCD din da LDL, idan aka kwatanta da daukar wuribo yin irin wannan salon rayuwa.
Kuma a shekara ta 2010, masu bincike daga jami'ar Pennsylvania sun nuna cewa a cikin marasa lafiyar da suka daina daukar nauyin kwayoyin saboda ciwo mai tsanani, RYR yana da tasiri kamar 20 mg a kowace rana na likitan magani na statin (Pravachol) a rage yawan matakan cholesterol. (Dukkan RYR da Pravachol sun samar da mummunan rauni na ciwon tsoka.)
A cikin binciken na 2009, masu binciken sunyi nazari kan sunadarai na RYR da suka kasance a cikin binciken (daga Sylvan Bioproducts a Kittanning, Pennsylvania). Sun gano cewa RYR har yanzu yana dauke da kwayar K da kuma wasu mawaki takwas.
Sakamakon wannan bincike na bincike yana nuna abubuwa biyu. Na farko, akalla wasu RYR da ke cikin Amurka suna da alaƙa a kalla wasu lovastatin, kuma na biyu, koda duk an cire dukkan lovastatin, sauran sunadarai masu kama da RYR (wanda FDA bai da - duk da haka - musamman ƙuntatawa) na iya zama tasiri a rage rage cholesterol .
Ya kamata ku karbi RYR?
A saman a kalla, ɗaukar RYR zai zama kamar la'akari da shawara mai kyau idan kuna nema takardun maganin cholesterol ragewa. Duk da haka, abin da za ku yi shi ne ɗaukar nauyin wasu abubuwa masu kama da stin. Ba za a iya faɗi ba, daga masu sayar da kayan aiki zuwa ga masu sana'a, ko ma daga kwalban zuwa kwalban, abin da kake sayarwa.
Idan kana so ka rage yawan cholesterol ba tare da rasa rigarka ga manyan kamfanonin likita ba, ka tambayi likitanka game da kwayoyin kwayoyi. Suna iya samuwa, ƙananan (watakila ma rahusa fiye da RYR), kuma a matsayin bonus, sakon da kake samo za a sani, kuma za'a iya sarrafawa kuma a gyara don inganta sakamakonka.
Sources:
Halbert SC, Faransanci B, Gordon RY, et al. Yiwuwar gishiri mai yisti mai yisti (2400 MG sau biyu) a kan prampastatin (20 MG sau biyu) a cikin marasa lafiya da tsohuwar statin rashin haƙuri. Am J Cardiol 2010; 105: 198-204.
Becker DJ, Gordon RY, Halbert SC, et al. Red yisti shinkafa don dyslipidemia a statin-marasa lafiya marasa lafiya. Ann Enter Med 2009; 150: 830-839.
Gordon RY, Cooperman T, Obermeyer W, Becker DJ. Alamar da aka yi la'akari da matakan da aka gina a cikin kayan sayar da shinkafa mai yisti mai sayarwa: mai saye ku kula! Arch Intern Med 2010; 170: 1722.